Expert Perspectives on Collaborative Management of Atopic Dermatitis
EP. 1: Overview of Atopic Dermatitis (AD)
ByLawrence F. Eichenfield, MD, Rady Children’s Hospital-San Diego ,Peter A. Lio, MD, Northwestern University Feinberg School of Medicine ,Elizabeth A. Swanson, St. Luke’s Children’s Hospital ,Jeffrey M. Bienstock, MD, FAAP, PediatriCare Associates 
EP. 2: Pathophysiology of Atopic Dermatitis
ByLawrence F. Eichenfield, MD, Rady Children’s Hospital-San Diego ,Peter A. Lio, MD, Northwestern University Feinberg School of Medicine ,Elizabeth A. Swanson, St. Luke’s Children’s Hospital ,Jeffrey M. Bienstock, MD, FAAP, PediatriCare Associates 
EP. 3: Flare-Ups in Atopic Dermatitis
ByLawrence F. Eichenfield, MD, Rady Children’s Hospital-San Diego ,Peter A. Lio, MD, Northwestern University Feinberg School of Medicine ,Elizabeth A. Swanson, St. Luke’s Children’s Hospital ,Jeffrey M. Bienstock, MD, FAAP, PediatriCare Associates Jeffrey Bienstock, MD, FAAP, identifies the various triggers causing flare-ups for atopic dermatitis in patients.
EP. 4: Diagnosis of Atopic Dermatitis
ByLawrence F. Eichenfield, MD, Rady Children’s Hospital-San Diego ,Peter A. Lio, MD, Northwestern University Feinberg School of Medicine ,Elizabeth A. Swanson, St. Luke’s Children’s Hospital ,Jeffrey M. Bienstock, MD, FAAP, PediatriCare Associates The role of multidisciplinary management in diagnosing atopic dermatitis and when patients typically seek care.
EP. 5: Outgrowing Atopic Dermatitis
ByLawrence F. Eichenfield, MD, Rady Children’s Hospital-San Diego ,Peter A. Lio, MD, Northwestern University Feinberg School of Medicine ,Elizabeth A. Swanson, St. Luke’s Children’s Hospital ,Jeffrey M. Bienstock, MD, FAAP, PediatriCare Associates Lawrence F. Eichenfield, MD; Jeffrey M. Bienstock, MD, FAAP; Peter A. Lio, MD; and Elizabeth A. Swanson, MD, discuss whether children outgrow atopic dermatitis and advice for the management of disease.
EP. 6: Comorbidities With Atopic Dermatitis
ByLawrence F. Eichenfield, MD, Rady Children’s Hospital-San Diego ,Peter A. Lio, MD, Northwestern University Feinberg School of Medicine ,Elizabeth A. Swanson, St. Luke’s Children’s Hospital ,Jeffrey M. Bienstock, MD, FAAP, PediatriCare Associates Elizabeth Swanson, MD, leads the discussion on emerging data on comorbid conditions associated with atopic dermatitis and management in the clinical setting.
EP. 7: Optimizing Multidisciplinary Care for Atopic Dermatitis
ByLawrence F. Eichenfield, MD, Rady Children’s Hospital-San Diego ,Peter A. Lio, MD, Northwestern University Feinberg School of Medicine ,Elizabeth A. Swanson, St. Luke’s Children’s Hospital ,Jeffrey M. Bienstock, MD, FAAP, PediatriCare Associates Lawrence F. Eichenfield, MD; Jeffrey M. Bienstock, MD, FAAP; Peter A. Lio, MD; and Elizabeth A. Swanson, MD, discuss the importance of an integrative approach to care for the management of atopic dermatitis.
EP. 8: New Models of Collaborative Care for Atopic Dermatitis
ByLawrence F. Eichenfield, MD, Rady Children’s Hospital-San Diego ,Peter A. Lio, MD, Northwestern University Feinberg School of Medicine ,Elizabeth A. Swanson, St. Luke’s Children’s Hospital ,Jeffrey M. Bienstock, MD, FAAP, PediatriCare Associates Reviewing the importance of newer models of collaboration between specialty and primary care for atopic dermatitis and educating patients and caregivers for disease management.
EP. 9: Patient Factors for Treatment of Atopic Dermatitis
ByLawrence F. Eichenfield, MD, Rady Children’s Hospital-San Diego ,Peter A. Lio, MD, Northwestern University Feinberg School of Medicine ,Elizabeth A. Swanson, St. Luke’s Children’s Hospital ,Jeffrey M. Bienstock, MD, FAAP, PediatriCare Associates Patient factors considered when prescribing treatment options for the management of atopic dermatitis.
EP. 10: Management of AD: Nonpharmacological Approaches
ByLawrence F. Eichenfield, MD, Rady Children’s Hospital-San Diego ,Peter A. Lio, MD, Northwestern University Feinberg School of Medicine ,Elizabeth A. Swanson, St. Luke’s Children’s Hospital ,Jeffrey M. Bienstock, MD, FAAP, PediatriCare Associates Peter Lio, MD, and Elizabeth Swanson, MD, provide insight on using nonpharmacological therapies and state-of-the-art skin care treatments for patients with atopic dermatitis.
EP. 11: Role of Nonsteroidal Topical Therapies in AD Management
ByLawrence F. Eichenfield, MD, Rady Children’s Hospital-San Diego ,Peter A. Lio, MD, Northwestern University Feinberg School of Medicine ,Elizabeth A. Swanson, St. Luke’s Children’s Hospital ,Jeffrey M. Bienstock, MD, FAAP, PediatriCare Associates Experts in the management of atopic dermatitis review the safety and efficacy of topical calcineurin inhibitors and topical PDE4 inhibitors.
EP. 12: Using Systemic Treatment in Atopic Dermatitis
ByLawrence F. Eichenfield, MD, Rady Children’s Hospital-San Diego ,Peter A. Lio, MD, Northwestern University Feinberg School of Medicine ,Elizabeth A. Swanson, St. Luke’s Children’s Hospital ,Jeffrey M. Bienstock, MD, FAAP, PediatriCare Associates A review of the safety and efficacy of systemic agents such as methotrexate, azathioprine, and cyclosporine in patients with severe, persistent atopic dermatitis.
EP. 13: Role of Disease-Modifying Therapy in Atopic Dermatitis
ByLawrence F. Eichenfield, MD, Rady Children’s Hospital-San Diego ,Peter A. Lio, MD, Northwestern University Feinberg School of Medicine ,Elizabeth A. Swanson, St. Luke’s Children’s Hospital ,Jeffrey M. Bienstock, MD, FAAP, PediatriCare Associates Examining the potential role for biologic, dupilumab, in the treatment of moderate to severe atopic dermatitis.
EP. 14: Accessing Dupilumab for Treatment of AD
ByLawrence F. Eichenfield, MD, Rady Children’s Hospital-San Diego ,Peter A. Lio, MD, Northwestern University Feinberg School of Medicine ,Elizabeth A. Swanson, St. Luke’s Children’s Hospital ,Jeffrey M. Bienstock, MD, FAAP, PediatriCare Associates A discussion on ease of access for dupilumab for the treatment of atopic dermatitis including the process for approval and coverage.
EP. 15: Emerging Agents for the Treatment of Atopic Dermatitis
ByLawrence F. Eichenfield, MD, Rady Children’s Hospital-San Diego ,Peter A. Lio, MD, Northwestern University Feinberg School of Medicine ,Elizabeth A. Swanson, St. Luke’s Children’s Hospital ,Jeffrey M. Bienstock, MD, FAAP, PediatriCare Associates Lawrence F. Eichenfield, MD; Jeffrey M. Bienstock, MD, FAAP; Peter A. Lio, MD; and Elizabeth A. Swanson, MD, review additional mechanisms being investigated in the pipeline for the treatment of atopic dermatitis.
